Janux Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 08, 2023 at 04:34 pm EDT
Janux Therapeutics, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 17.51 million compared to USD 16.89 million a year ago. Basic loss per share from continuing operations was USD 0.42 compared to USD 0.41 a year ago.
For the six months, net loss was USD 34.97 million compared to USD 30.3 million a year ago. Basic loss per share from continuing operations was USD 0.84 compared to USD 0.73 a year ago.